Recognizing red flags in genetic cardiomyopathy: the importance of genetic testing. [PDF]
Gerges S, Chouairi S, Naoufal R.
europepmc +1 more source
When Off-Target <i>Is</i> the Target: Treating Noncardiomyocytes in Cardiac Laminopathy. [PDF]
Kirk JA.
europepmc +1 more source
Twenty-Five-Year Follow-Up of the MDDC1 Family: A <i>LMNA</i> Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement. [PDF]
Capovilla TM +11 more
europepmc +1 more source
A Rare Instance of Concordant Charcot-Marie-Tooth Disease and Familial Partial Lipodystrophy Type 2. [PDF]
Bachir MA +4 more
europepmc +1 more source
Familial partial lipodystrophy type 2 associated with a novel LMNA variant (c.604G>C; p.Glu202Gln): a Colombian family case series. [PDF]
Mendoza C, Cano R, Burgos L, Silvera CA.
europepmc +1 more source
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence. [PDF]
DiCintio AJ, Joudeh LA, Waldman AS.
europepmc +1 more source
Optimized simple culture protocol for inducing mature myotubes from MYOD1-overexpressed human iPS cells. [PDF]
Wada E +5 more
europepmc +1 more source
Molecular mechanism on autophagy associated cardiovascular dysfunction in <i>Drosophila melanogaster</i>. [PDF]
Zhang W +15 more
europepmc +1 more source
How to Screen and Manage Suspected Laminopathy. [PDF]
Kataoka N, Sugiyama T, Imamura T.
europepmc +1 more source
Exploring a targeted epigenetic clock based on mortality-associated CpGs as a potential biomarker for frailty. [PDF]
Awuah J +6 more
europepmc +1 more source

